Multiplex Immunohistochemistry (mIHC) vs. Immunofluorescence (IF): Key Knowledge and Research Hotspots Empowered by ANT BIO PTE. LTD.

1. Concept

In life science research, in situ antigen detection is crucial for exploring biological molecule distribution and expression. Multiplex Immunohistochemistry (mIHC) and Immunofluorescence (IF) are core technologies relying on antigen–antibody binding, with distinct principles and performance.

Immunofluorescence (IF), a classic labeled immunoassay, localizes antigens in tissues/cells by combining antibodies with fluorescent tracers, based on immunology, biochemistry and microscopy.

Derived from Tyramide Signal Amplification (TSA), mIHC uses HRP for high-density target labeling, compatible with various dyes. Its core advantage is geometric signal amplification, enabling simultaneous high-sensitivity detection of multiple targets on one tissue section.

2. Research Frontiers

With the development of immuno-oncology and precision medicine, demand for multi-target, high-sensitivity in situ detection is surging. Key research frontiers of mIHC and IF include:

• Multi-target expansion: Optimizing mIHC’s TSA system to detect over 10 biomarkers for revealing tissue microenvironment interactions.
• Sensitivity/specificity improvement: Developing anti-quenching probes for IF; optimizing tyramide derivatives and HRP for mIHC to enhance signal-to-noise ratio.
• Single-cell integration: Combining mIHC with single-cell sequencing for single-cell quantitative analysis, a hotspot in tumor and immune research.
• Clinical application: Expanding to tumor screening, prognosis and targeted therapy guidance, with mIHC showing greater potential in multi-marker diagnosis.

ANT BIO PTE. LTD. follows these frontiers, optimizing products to support cutting-edge research.

3. Research Significance

mIHC and IF are vital for life science and clinical medicine development.

In basic research, they enable accurate antigen localization/quantification, helping reveal disease mechanisms, signaling pathways and immune cell interactions.

In clinical practice, mIHC supports personalized tumor treatment via multi-target detection, while IF facilitates rapid sample screening and pathological verification.

Their innovation also drives progress in antibody engineering, fluorescent probes and image analysis.

4. Related Mechanisms, Research Methods and Product Applications

4.1 Core Mechanisms

IF relies on antigen–antibody binding; fluorescent probes on secondary antibodies emit light under excitation for antigen visualization.

mIHC’s TSA mechanism: HRP-catalyzed tyramide forms covalent sites, depositing biotin at binding sites. Streptavidin-HRP/fluorescent group binding and cyclic amplification achieve geometric signal enhancement.

4.2 Common Research Methods

IF includes direct (simple but low-sensitivity) and indirect (high-sensitivity, widely used) methods. mIHC uses step-by-step staining with TSA amplification and antibody elution to avoid interference.

4.3 Product Applications of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides full research support via three sub-brands:

• Absin: Offers 4–7 color mIHC staining kits (compatible with TSA) and general reagents for experimental smoothness.
• Starter: Provides high-specificity same-species primary antibodies for mIHC and different-species ones for IF, ensuring binding specificity.
• UA: Supplies high-purity recombinant proteins for antigen–antibody verification and experimental standards.

5. Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.